| Page 619 | Kisaco Research

Reverse engineering refers to the process of working backward from an available product to understand what its parts are, how it functions and/or how it was made. This panel of trade secret experts will you to understand the permissibility of this process under federal and state law.

 

-        Discover the major trade secret case law regarding “reverse engineering and understand the key takeaways.

-        Is reverse engineering permissible under the DTSA?

-        What are the legal principles of reverse engineering in the high-tech industry?

  • Does this differ from other West Coast industries?
 

Jarron Aizen

Founder and CEO
Hapana

As Founder and CEO, Jarron spearheads Hapana, the leading full-stack fitness software solution designed exclusively for boutique fitness businesses with multi site expansion plans. With a combined technical and commercial background, Jarron is an OnDeck Fellow and fitness industry veteran, leading all aspects of the Hapana vision, product suite, team culture and global expansion.

Jarron Aizen

Founder and CEO
Hapana

Jarron Aizen

Founder and CEO
Hapana

As Founder and CEO, Jarron spearheads Hapana, the leading full-stack fitness software solution designed exclusively for boutique fitness businesses with multi site expansion plans. With a combined technical and commercial background, Jarron is an OnDeck Fellow and fitness industry veteran, leading all aspects of the Hapana vision, product suite, team culture and global expansion.

 

Tom Hale

Chief Executive Officer
ŌURA Health

Tom Hale is the Chief Executive Officer at ŌURA Health and a member of its board. As the CEO he sets the company’s business strategy and vision to make health a daily practice for members all over the world. He has over 30 years of experience across the technology and consumer product industry. Before joining ŌURA, Hale was president of Momentive where he drove B2B strategy and led product growth.

Tom Hale

Chief Executive Officer
ŌURA Health

Tom Hale

Chief Executive Officer
ŌURA Health

Tom Hale is the Chief Executive Officer at ŌURA Health and a member of its board. As the CEO he sets the company’s business strategy and vision to make health a daily practice for members all over the world. He has over 30 years of experience across the technology and consumer product industry. Before joining ŌURA, Hale was president of Momentive where he drove B2B strategy and led product growth. During his time there he was instrumental in taking the company public in 2018, leading the team in key acquisitions, and driving the evolution and rebranding of the company into a multiple SAAS business. Previously, he held leadership roles at HomeAway and Linden Lab as the Chief Operating Officer and Chief Product Officer, respectively, and held executive roles at Macromedia and Adobe.


Hale has a Bachelor of Arts from Harvard University and sits on the boards Cars.com, RocketReach, and NoiseAware

 

Emma Barry

Chief of Trouble
Trouble Global

Emma Barry

Chief of Trouble
Trouble Global

Emma Barry

Chief of Trouble
Trouble Global
 

Harriette Brainard

Director of Operations, Comunications
Soil In Formation (SIF)

Harriette Brainard

Director of Operations, Comunications
Soil In Formation (SIF)

Harriette Brainard

Director of Operations, Comunications
Soil In Formation (SIF)
 

Robert Molander

CCO
Infant Bacterial Therapeutics

Robert has over 25 years of experience working in life science organizations with launching and commercializing pharmaceuticals in the United States at organizations such as Pfizer and Novartis. He has also served as an Executive Council Member at the Harvard Medical School. Robert holds an MBA from Washington University and bachelor’s degrees from Miami University in Economics and International Studies.

Robert Molander

CCO
Infant Bacterial Therapeutics

Robert Molander

CCO
Infant Bacterial Therapeutics

Robert has over 25 years of experience working in life science organizations with launching and commercializing pharmaceuticals in the United States at organizations such as Pfizer and Novartis. He has also served as an Executive Council Member at the Harvard Medical School. Robert holds an MBA from Washington University and bachelor’s degrees from Miami University in Economics and International Studies.